Our bodies naturally produce hormones as part of normal healthy functioning. It is well-known that hormones, especially sex-steroid hormones like estrogen, are related to cancer initiation and progression. DCEG researchers are actively investigating how the body’s own hormone production may be related to risk for breast, endometrial, and ovarian cancer as well as testicular cancer and other malignancies. We study not only levels of circulating estrogens in the body, but also individual variability in the ratio of estrogen metabolites.
Estrogens play important roles in the pathophysiology of breast tumors and are recognized causal factors in the etiology of breast cancer; this central insight has led to many of the available preventive and therapeutic interventions for breast cancer. Endogenous estrogens may also play causal roles in endometrial and ovarian cancers and could also be important in male reproductive cancers, such as male breast cancer, testicular cancer, and prostate cancer. Substantial inter-individual variability has been observed in levels of circulating and excreted estrogens and estrogen metabolites (jointly referred to as EM) among men, postmenopausal women, and premenopausal women. Because EM vary with respect to bioavailability, affinity to estrogen receptors, and mutagenic potential, investigators have hypothesized that variations in estrogen profiles may account for interindividual differences in cancer risks. Until recently, it has been difficult to study this hypothesis in epidemiologic settings. Recent development of a liquid chromatography-tandem mass spectrometry (LC/MS2) method for measurement of estrogens and estrogen metabolites in urine (Xu et al., Anal Chem 2006;78:1553) and serum (Xu et al., Anal Chem 2007;79:7813) represents an important methodologic development because it provides an assay with characteristics that make it feasible for use in epidemiologic studies: high sensitivity, specificity, reliability, and scalability for high-throughput work.
A study that aims to characterize the radiologic, histologic, and molecular features of dense breast tissue
A study established as part of NCI's Biological Markers Project to identify serum markers for breast cancer
A retrospective cohort study that uses data from the FIT clinical trial to evaluate how bone mineral density of the hip is related to subsequent cancer risk; including a nested case-cohort study of circulating sex steroid hormones in relation to breast, endometrial, ovarian, and colorectal cancer risk
A population-based case-control study of breast cancer in Poland that combines state-of-the art techniques of exposure assessment and collection of biological specimens
A nested case-control study of endometrial and ovarian cancers assessing the roles of estrogens, estrogen metabolites, androgens, and androgen metabolites in the etiologies of these cancers
A case-control study of testicular cancer among military servicemen
Studies to assess methods for measurement of estrogens/estrogen metabolites, androgens/androgen metabolites, pregnenolone, and progesterone/progesterone metabolites
A study to investigate to what extent blood (circulating) concentrations of sex hormones represent concentrations within the prostate